Physician profile

Joseph Golden

Cardiovascular Disease · Shreveport, LA

NPI 1518496850

$5,094.30

in general payments reported to CMS, 2019-2025

31 companies · $2,028 in 2025

The $2,028 reported for 2025 was more than what 84% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

See the full distribution for Cardiovascular Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$4,273.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abiomed $1,241.03 2023-2025 Impella
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $570.38 2021-2025 Lifevest
Boston Scientific Corporation $465.66 2023-2025 Ekosonic, Bodyguardian, Opticross 35
Shockwave Medical, INC $334.13 2025
Medtronic, INC. $294.14 2022-2025 Corevalve Evolut R, Symplicity G3
Kestra Medical Technology Services, INC. $249.12 2024-2025 Assure Wcd
Merck Sharp & Dohme LLC $185.89 2021-2025 Verquvo, Bridion
Amgen INC. $178.99 2023-2025 Repatha, Repatha
Sanofi-Aventis U.S. LLC $166.26 2021-2024
Stryker Corporation $166.08 2025 Artix Mt, Clottriever Bold Catheter, Ct Thrombectomy System Kit
Inari Medical, INC. $157.47 2023 Ct Thrombectomy System Kit, Flowtriever Catheter, S
Itamar Medical INC $153.58 2025 Watchpatone
Actelion Pharmaceuticals US, INC. $125.00 2023 Uptravi, Opsumit
Abbott Laboratories $110.30 2022-2025 Diamondback Coronary
Boehringer Ingelheim Pharmaceuticals, INC. $97.11 2021-2024 Jardiance
Show all 31 companies
CompanyGeneral paymentsYearsTop products
Astrazeneca Pharmaceuticals LP $91.27 2021-2025 Farxiga
Chiesi USA, INC. $72.00 2023 Kengreal
Pfizer INC. $56.66 2021-2025
Novo Nordisk INC $51.14 2024-2025 Wegovy, Rybelsus, Ozempic
Penumbra, INC. $48.00 2023 Indigo System
Bayer Healthcare Pharmaceuticals INC. $44.26 2025
E.R. Squibb & Sons, L.L.C. $40.48 2021-2023 Camzyos
Inspire Medical Systems, INC. $40.26 2025 Inspire
Irhythm Technologies, INC. $25.32 2024 Zio Xt Patch, Zio Monitor
Zoll Circulation INC $24.81 2023 Downstream Cartridge, Catheter, Therox Ds2 Console
Kiniksa Pharmaceuticals International, Plc $23.48 2024 Arcalyst
Lilly USA, LLC $20.13 2025 Mounjaro
Ambu INC. $19.52 2024
Philips North America LLC $14.58 2025 Ecc Solutions
Bard Peripheral Vascular, INC. $13.90 2024 Lutonix Drug Coated Balloon
Janssen Pharmaceuticals, INC $13.35 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Joseph Golden

$5,094.30

in general payments reported 2019-2025

Years
2020-2025
Top company
Abiomed
Context
The $2,028 reported for 2025 was more than what 84% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/3392836/joseph-golden

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.